EP08.02-027 T790M Detection Rate After First-Line Treatment with Bevacizumab Plus 1st or 2nd Generation EGFR-TKI in Advanced NSCLC

Autor: C.-H. Kuo, P.-L. Su, Y.-F. Wei, J.-C. Ko, J.-S. Tseng, J. Su, C.-L. Chiang, C.-Y. Chen, C.-C. Lin, C.-C. Wang, C.-C. HO, H.C. Chang, J.-Y. Hung
Rok vydání: 2022
Předmět:
Zdroj: Journal of Thoracic Oncology. 17:S409-S410
ISSN: 1556-0864
DOI: 10.1016/j.jtho.2022.07.709
Databáze: OpenAIRE